DMAA (1,3-dimethylamylamine) has been included in Appendix C of the Poisons Standard. The inclusion in Appendix C means that that the sale, supply and use of DMAA will be prohibited.
The TGA made its decision in response to safety concerns about the abuse of DMAA and following advice from the Advisory Committee on Medicines Scheduling (ACMS) and public consultation.
After a scheduling decision by the TGA, state and territory governments implement any necessary changes to legislation. State and territory authorities are responsible for enforcing these laws.
DMAA acts as a stimulant and is used in pre-workout sports supplements and ‘party pills’ to provide an adrenaline-like high. It has been linked with various adverse health effects including high blood pressure, headaches, vomiting, cerebral haemorrhage, stroke and death.
New Zealand banned DMAA from all products in April this year after reports of adverse effects.
Source: FSANZ
.
© FoodBev Media Ltd 2024